• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Rheumatology

Show Search
Hide Search
  • About Us
    • Our History
    • Our Faculty
    • Rheumatology Fellowship
    • Administrative Core
    • Contact Us
    • eNews Signup
  • Make an Appointment
    • Clinic Information
    • Specialty Clinics
  • Our Research
    • Current Research Studies
    • Andrade Lab
    • Antiochos Lab
    • Casciola-Rosen Lab
    • Darrah Lab
    • Konig Lab
    • RDRCC
    • Bayview Immunomics Core (BIC)
  • Charitable Giving
    • Dr. John Welton Fellowship in Rheumatology
    • Dr. Ira T. Fine Discovery Fund
    • Dr. Nadia D. Morgan Memorial Fund
  • News
    • LEAP Magazine
  • Education
    • Advances in the Diagnosis and Treatment of the Rheumatic Diseases Course
    • RheumTV – Patient Education Video Library
Home / News / Research / Myositis Patients, Caregivers, and Healthcare Providers Weigh-in About What is Most Important to Them

Myositis Patients, Caregivers, and Healthcare Providers Weigh-in About What is Most Important to Them

November 9, 2018 By Johns Hopkins Rheumatology

Summary

Patient-reported outcome measures that incorporate the patient perspective have not been well established in inflammatory myositis. We therefore conducted a large, international survey to better understand what areas are viewed as important by different groups. Our results indicate that substantial differences exist in how myositis is perceived by patients compared to healthcare providers, with different items prioritized. In contrast, patients’ views across the world were largely similar.

Why was the study done?

To date, it is largely unknown what issues myositis patients feel are most important about their disease, and how these areas compare and contrast with those of their healthcare team. As part of our goal to develop patient-reported outcome measures for myositis patients, the Outcome Measures in Rheumatology (OMERACT) Myositis special interest group sought to determine which aspects of the disease and its effects are important to patients and healthcare providers. The Myositis special interest group consists of healthcare providers and patients from the USA, the Netherlands, Sweden, South Korea, and Australia.

How was the study done?

An international survey was sent to patients with inflammatory myositis (dermatomyositis, polymyositis, necrotizing myopathy, or antisynthetase syndrome), their primary caregivers, and healthcare providers to identify the important items that, from their perspective, should be assessed in clinical research.

What were the major findings?

In this survey, a total of 638 individuals completed the survey, consisting of 510 patients, 101 healthcare providers, and 27 caregivers from 48 countries. Overall, patients were more likely to rank “fatigue,” “cognitive impact,” and “difficulty sleeping” higher compared with healthcare providers, who ranked “joint symptoms,” “lung symptoms,” and “trouble swallowing” higher. Both patients and providers rated muscle symptoms as their top domain. In general, patients from different countries were in agreement on which domains were most important to them. One notable exception was that patients from Sweden and the Netherlands ranked lung symptoms significantly higher compared to other countries including the United States and Australia.

What is the impact of this work?

This work highlights the discordance between what patients and healthcare providers view as the important features of myositis. This work will further inform the development of patient-reported outcome measures to be used in research – outcomes which are rooted in the patient perspective.

This research supported by:

  • The Jerome L. Greene Foundation

Link to original publication:

Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study
Christopher A. Mecoli, Jin Kyun Park, Helene Alexanderson, Malin Regardt, MerrileeNeedham, Ingrid de Groot, Catherine Sarver, Ingrid E. Lundberg, Beverley Shea, Mariannede Visser, Yeong Wook Song, Clifton O. Bingham, Lisa Christopher-Stine
The Journal of Rheumatology Sep 2018, jrheum.180353; DOI: 10.3899/jrheum.180353
Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Filed Under: Research

Johns Hopkins Rheumatology

The Division of Rheumatology is a thriving clinical and academic center, which concentrates clinically on providing the most outstanding care to patients affected by a variety of common and uncommon rheumatic disorders.

Use of this Site

All information contained within the Johns Hopkins Division of Rheumatology website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Rheumatology News

  • News
  • Promotions

Recent News

LEAP Winter 2025: Fighting Fire with Fire

February 27, 2025

LEAP Winter 2024: At the Cusp of Breakthroughs

February 23, 2024

LEAP – Winter 2023: Big Data, Individualized Care

February 23, 2024

RheumTV Logo

Rheum.TV is an educational platform created to help patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit RheumTV

Footer

Rheumatology Specialty Care Centers

  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect with Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2025 Johns Hopkins Rheumatology - Patient Privacy